Sigma Planning Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8M Buy
62,029
+5,738
+10% +$1.34M 0.4% 37
2026
Q1
$13.8M Sell
56,291
-665
-1% -$155K 0.38% 42
2025
Q4
$11.8M Buy
56,956
+4,678
+9% +$925K 0.33% 51
2025
Q3
$9.69M Sell
52,278
-3,399
-6% -$582K 0.28% 60
2025
Q2
$8.5M Sell
55,677
-3,559
-6% -$547K 0.26% 69
2025
Q1
$9.82M Sell
59,236
-1,383
-2% -$216K 0.31% 55
2024
Q4
$8.77M Sell
60,619
-1,574
-3% -$244K 0.28% 59
2024
Q3
$10.1M Buy
62,193
+486
+0.8% +$77.4K 0.31% 60
2024
Q2
$9.02M Sell
61,707
-5,484
-8% -$816K 0.29% 63
2024
Q1
$10.6M Buy
67,191
+39,465
+142% +$6.28M 0.33% 50
2023
Q4
$4.35M Sell
27,726
-48,905
-64% -$7.5M 0.34% 56
2023
Q3
$11.9M Sell
76,631
-13,313
-15% -$2.2M 0.45% 36
2023
Q2
$14.9M Sell
89,944
-15,836
-15% -$2.56M 0.53% 29
2023
Q1
$16.4M Buy
105,780
+2,164
+2% +$349K 0.54% 26
2022
Q4
$18.3M Sell
103,616
-3,160
-3% -$546K 0.65% 20
2022
Q3
$17.4M Sell
106,776
-1,599
-1% -$271K 0.66% 20
2022
Q2
$19.2M Sell
108,375
-1,654
-2% -$295K 0.67% 21
2022
Q1
$19.5M Sell
110,029
-1,335
-1% -$227K 0.58% 27
2021
Q4
$19.1M Buy
111,364
+4,362
+4% +$714K 0.53% 32
2021
Q3
$17.3M Buy
107,002
+781
+0.7% +$133K 0.52% 30
2021
Q2
$17.5M Sell
106,221
-8,794
-8% -$1.46M 0.52% 30
2021
Q1
$18.9M Buy
115,015
+1,996
+2% +$323K 0.6% 22
2020
Q4
$17.8M Sell
113,019
-237
-0.2% -$35K 0.6% 22
2020
Q3
$16.9M Sell
113,256
-2,984
-3% -$442K 0.67% 17
2020
Q2
$16.3M Buy
116,240
+14,773
+15% +$2.15M 0.72% 15
2020
Q1
$13.3M Sell
101,467
-829
-0.8% -$118K 0.79% 18
2019
Q4
$14.9M Buy
102,296
+653
+0.6% +$88.6K 0.63% 23
2019
Q3
$13.2M Buy
101,643
+9,921
+11% +$1.31M 0.63% 24
2019
Q2
$12.8M Buy
91,722
+9,693
+12% +$1.34M 0.66% 20
2019
Q1
$11.5M Buy
82,029
+4,221
+5% +$565K 0.65% 25
2018
Q4
$10M Sell
77,808
-6,877
-8% -$959K 0.73% 22
2018
Q3
$11.7M Buy
84,685
+1,969
+2% +$262K 0.69% 25
2018
Q2
$10M Sell
82,716
-7,777
-9% -$970K 0.67% 28
2018
Q1
$11.6M Buy
90,493
+4,231
+5% +$572K 0.85% 19
2017
Q4
$12.1M Buy
86,262
+5,538
+7% +$771K 0.93% 11
2017
Q3
$10.5M Buy
80,724
+2,620
+3% +$347K 0.87% 14
2017
Q2
$10.3M Sell
78,104
-5,695
-7% -$726K 0.97% 8
2017
Q1
$10.4M Buy
83,799
+14,639
+21% +$1.75M 1.01% 9
2016
Q4
$7.97M Buy
69,160
+5,632
+9% +$651K 0.87% 18
2016
Q3
$7.5M Buy
63,528
+2,717
+4% +$330K 0.89% 14
2016
Q2
$7.38M Sell
60,811
-8,835
-13% -$1M 0.96% 14
2016
Q1
$7.54M Sell
69,646
-104
-0.1% -$10.8K 1.03% 12
2015
Q4
$7.17M Buy
69,750
+12,872
+23% +$1.29M 1% 11
2015
Q3
$5.31M Sell
56,878
-3,667
-6% -$355K 0.84% 14
2015
Q2
$5.9M Sell
60,545
-2,558
-4% -$256K 0.81% 12
2015
Q1
$6.35M Buy
63,103
+1,169
+2% +$119K 0.84% 10
2014
Q4
$6.48M Buy
+61,934
New +$6.53M 0.86% 14

Other funds holding JNJ

Sigma Planning Corp's JNJ Position: Q2 2026 in Review

Sigma Planning Corp increased its Johnson & Johnson (JNJ) stake by 10% in Q2 2026, buying an estimated $1.34M and bringing the position to 62,029 shares worth $15.8M. The position accounts for 0.4% of the portfolio, ranked #37.

Sigma Planning Corp first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $19.5M in Q1 2022. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sigma Planning Corp held 62,029 shares of Johnson & Johnson worth $15.8M as of Q2 2026.
  • Sigma Planning Corp bought 5,738 Johnson & Johnson shares in Q2 2026, an estimated $1.34M.
  • Johnson & Johnson made up 0.4% of Sigma Planning Corp's portfolio in Q2 2026, its #37 holding.
  • Sigma Planning Corp first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • Sigma Planning Corp's Johnson & Johnson position peaked at $19.5M in Q1 2022.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.